학술논문
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe
Document Type
Short Communication
Source
In Clinical Microbiology and Infection September 2024 30(9):1197-1197
Subject
Language
ISSN
1198-743X